These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17172718)

  • 1. Novel opportunities for therapeutic targeting in systemic autoimmune diseases.
    Ouarzane M; Zouali M
    Methods Mol Biol; 2007; 361():285-97. PubMed ID: 17172718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.
    Sun J; Lin Z; Feng J; Li Y; Shen B
    Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.
    Mackay F; Silveira PA; Brink R
    Curr Opin Immunol; 2007 Jun; 19(3):327-36. PubMed ID: 17433868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAFF: a novel therapeutic target for autoimmunity.
    Kalled SL
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1005-10. PubMed ID: 12186259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review.
    Lied GA; Berstad A
    Scand J Immunol; 2011 Jan; 73(1):1-7. PubMed ID: 21128997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target.
    Baker KP
    Autoimmun Rev; 2004 Jul; 3(5):368-75. PubMed ID: 15288003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.
    Cancro MP
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii34-6. PubMed ID: 17038469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell receptor signaling in human systemic lupus erythematosus.
    Pugh-Bernard AE; Cambier JC
    Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases.
    Krivosikova M; Dallos T; Maslinski W; Buc M
    Bratisl Lek Listy; 2009; 110(3):137-45. PubMed ID: 19507632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
    Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
    Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas.
    Sutherland AP; Mackay F; Mackay CR
    Pharmacol Ther; 2006 Dec; 112(3):774-86. PubMed ID: 16863659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
    Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
    J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The late news on baff in autoimmune diseases.
    Youinou P; Pers JO
    Autoimmun Rev; 2010 Oct; 9(12):804-6. PubMed ID: 20656068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95).
    Hancz A; Hérincs Z; Neer Z; Sármay G; Koncz G
    Immunol Lett; 2008 Mar; 116(2):211-7. PubMed ID: 18243342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell targeted therapies in human autoimmune diseases: an updated perspective.
    Townsend MJ; Monroe JG; Chan AC
    Immunol Rev; 2010 Sep; 237(1):264-83. PubMed ID: 20727041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increase in B cell apoptosis by interfering BAFF-BAFF-R interaction with small synthetic molecules.
    Moon EY; Yi KY; Lee S
    Int Immunopharmacol; 2011 Oct; 11(10):1523-33. PubMed ID: 21620999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
    Gross JA; Johnston J; Mudri S; Enselman R; Dillon SR; Madden K; Xu W; Parrish-Novak J; Foster D; Lofton-Day C; Moore M; Littau A; Grossman A; Haugen H; Foley K; Blumberg H; Harrison K; Kindsvogel W; Clegg CH
    Nature; 2000 Apr; 404(6781):995-9. PubMed ID: 10801128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH; Aringer M
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.